Cannabidiol (CBD) has become a household term lately, yet there is so much confusion around source, mechanism of action, quality, and efficacy. While data is slowly accumulating behind cannabis, the science regarding source and purity are well known and clinical data is a major focus. Webinar presented by Dr. Sahar Swidan, Pharm. D., BCPS.
Dr. Sahar Swidan is a key thought leader in the Cannabis space, serving as the Executive Director at Slyngshot Health and on the Editorial Board for the Cannabis Journal of Medicine. With over 25 years of experience in Personalized Medicine and Pharmacogenomics, Dr. Swidan has a diverse background ranging from academic faculty at various universities to management in many roles.